Search results
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 6 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Shah Capital ends campaign against Novavax board after Sanofi deal
WSAU Wausau· 5 days ago(Reuters) - Hedge fund Shah Capital said on Monday it would withdraw its campaign against the...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 5 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Novavax (NASDAQ:NVAX) Trading 3.4% Higher
ETF DAILY NEWS· 2 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) shot up 3.4% during trading on Wednesday . 1,132,956 shares changed hands during trading, a decline of 90% from the average session ...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 5 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 2 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 6 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 3 days agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....